Drug Prices Not Responsible For Premium Hikes - HIAA, PhRMA Studies
Executive Summary
Only a small part of recent increases in health insurance premiums can be attributed to the cost of prescription drugs, according to two reports released the week of April 10 by the pharmaceutical and health insurance industries.
You may also be interested in...
PBMs Could Reduce Rx Spending By 25% Under GOP Medicare Plan - CBO
The Congressional Budget Office estimates that pharmacy benefit management companies will generate a 25% reduction in retail drug costs under the House Medicare drug benefit bill.
PBMs Could Reduce Rx Spending By 25% Under GOP Medicare Plan - CBO
The Congressional Budget Office estimates that pharmacy benefit management companies will generate a 25% reduction in retail drug costs under the House Medicare drug benefit bill.
Medicare Drug Benefit Could Use Medicaid Price As Ceiling - Schondelmeyer
Congress should consider using Medicaid prices as a ceiling for a federal Medicare drug benefit program, University of Minnesota PRIME Institute Director Stephen Schondelmeyer, PhD, suggested during a June 13 House Ways & Means Committee hearing.